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Abstract
Background: Cervical cancer is the third most commonly occurring cancer among women and the fourth leading
cause of cancer-related deaths in women worldwide, with more than 85 % of these cases occurring in developing
countries. These global disparities reflect the differences in cervical cancer screening rates between high-income
and medium- and low-income countries. At 19 %, El Salvador has the lowest reported screening coverage of all
Latin American countries. The purpose of this study is to identify factors affecting public sector HPV DNA-based
cervical cancer screening participation in El Salvador.
Methods: This study was nested within a public sector screening program where health promoters used door-to-door
outreach to recruit women aged 30–49 years to attend educational sessions about HPV screening. A subgroup of these
participants was chosen randomly and questioned about demographic factors, healthcare utilization, previous cervical
cancer screening, and HPV knowledge. Women then scheduled screening appointments at their public health clinics.
Screening participants were adherent if they attended their scheduled appointment or rescheduled and were screened
within 6 months. The association between non-adherence and demographic variables, medical history, history of
cancer, sexual history, birth control methods, and screening barriers was assessed using Chi-square tests of significance
and logistic regression.
Results: All women (n = 409) enrolled in the study scheduled HPV screening appointments, and 88 % attended.
Non-adherence was associated with a higher number of lifetime partners and being under-screened—defined
as not having participated in cervical cancer screening within the previous 3 years (p = 0.03 and p = 0.04,
respectively); 22.8 % of participants in this study were under-screened.
Conclusions: Adherence to cervical cancer screening after educational sessions was higher than expected, in
part due to interactions with the community-based health promoters as well as the educational session itself.
More effective recruitment methods targeted toward under-screened women are required.
Keywords: HPV, Community health promoters, Cervical cancer, Adherence, Screening, Underserved
populations, Education
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Background
Cervical cancer is one of the leading causes of
cancer-related mortality among women in low- and
middle-income countries (LMICs) globally and in Latin
America [1]. An estimated 529,828 cases and 275,125
deaths occur annually world-wide due to cervical cancer,
with LMICs carrying more than 85 % of the burden of dis-
ease [2]. In Latin America and the Caribbean, the inci-
dence and mortality rates are 21.2/100,000 and 8.7/
100,000 respectively [3]. El Salvador has one of the highest
rates of the region, with an incidence of 25/100,000 and a
mortality rate of 11.8/100,000 [3].
El Salvador has a population of 2.41 million women,
age 15 and older, who are at risk of developing cervical
cancer in their lifetime, with current estimates of 823
new diagnoses and 388 deaths annually [4]. When com-
pared to other Latin American countries, El Salvador
has the lowest reported screening coverage. A National
Family Health Survey (FESAL) 2008 report showed
screening coverage to be 87.2 % overall, with 67.5 % of
women screened every 2 years, and 45.0 % screened
every year, but coverage levels decreased in the more
rural areas of the country, with only 82.7 % of women
having a history of screening, and 63.3 % of these
women being screened within the last 2 years [4].
Among women with an abnormal screening result,
follow-up is incomplete. According to a study conducted
by Pan American Health Organization (PAHO) in 2002,
24 % (22/90) of women with abnormal Pap smear results
did not receive a follow-up colposcopy [5].
To decrease this burden, numerous studies have tested
interventions aimed at increasing cervical cancer screen-
ing with a particular focus on appointment attendance.
Successful strategies have included scheduling appoint-
ments, mailing letters, making phone calls, conducting
educational and counseling programs, and managing
community-based outreach programs [6–8]. While most
of these studies took place in developed countries, a few
small-scale studies have been conducted in LMICs and
demonstrated that cervical cancer education programs
can increase knowledge, screening intention, and screen-
ing participation [9, 10].
Socio-demographic factors that have been shown to be
associated with higher attendance rates in LMICs in-
clude relative higher wealth, seeking healthcare at health
facilities when sick, and satisfaction with services at the
health facility [11]. Structural and interpersonal barriers
to screening include lack of knowledge of available ser-
vices, financial constraints, family responsibilities, diffi-
culty obtaining transportation, dissatisfaction with care,
disapproval by a male partner, or discomfort with a male
provider [11–16]. To date, studies of cervical cancer
screening adherence in the context of a program that in-
cludes an educational session have not been performed
among populations in rural Central America. Further-
more, the factors that influence women’s screening ad-
herence rates in El Salvador are unidentified/unknown.
The purpose of this study is to identify the facilitators
and barriers to HPV screening which could be instru-
mental when developing interventions for El Salvador as
well as for other LMIC countries. The Cervical Cancer
Prevention in El Salvador (CAPE) HPV screening pro-
gram provided an opportunity to conduct this study
within the initiative. CAPE was led by the Salvadoran
Ministry of Health (MOH) in partnership with the non-
profit organization, Basic Health International (BHI), to
initiate HPV-based screening in the public sector using
careHPV (QIAGEN Gaithersburg Inc., Gaithersburg,
MD, USA) among approximately 30,000 women.
Methods
This study was reviewed and approved by the Institu-
tional Review Board of the University of Pittsburgh and
the National Ethical Review Board of El Salvador.
The Factors Determining Screening Adherence Study
(Adherence Study) was nested in the first phase of the
CAPE program that introduced HPV screening to 2000
women at four rural health units in the Paracentral re-
gion of El Salvador (San Pedro Perulapan, San Rafael
Cedros, Apastepeque, and San Sebastián). These units
are responsible for providing primary preventive care. .
The health promoters and MOH administration used
the 2010 census to identify all women age 30–49 years
potentially eligible for HPV testing in their catchment
areas (n = 11,421). Health promoters are local employees
of the MOH who reside in the communities in which
they work and promote preventive health initiatives by
providing education and counseling
Figure 1 outlines the first phase of the CAPE program
and the nested Adherence Study. The MOH-led CAPE
program recruited women between October 2012 and
March 2013 to receive HPV screening as part of an imple-
mentation program. Health promoters used health unit cy-
tology registries to identify women not screened within
the past 3 years and visited them in their home to promote
screening. At the visits, many women (number not re-
corded in the CAPE program) reported that their screen-
ing history in the cytology registry was outdated because
they had been screened in the past 3 years during a public
health campaign or at some other occasion. Since this was
an implementation rather than a research program, the
Ministry of Health made the decision that screening would
be based on age rather than screening history. This deci-
sion was made because preliminary data showed similar
HPV positivity rates regardless of screening history. There-
fore, all women age 30–49 years, not pregnant, able to
provide informed consent, and without history of pre-
vious lesion or cryotherapy, loop electrosurgical
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excision procedure (LEEP), or hysterectomy were
deemed eligible for HPV screening in the CAPE pro-
gram (n = 2649).
Women were invited to attend an educational session
in their community focusing on cervical cancer preven-
tion and HPV testing. At this session, eligibility criteria
were confirmed because some women attending had not
been invited by a health promoter but instead self-
referred outside of CAPE (number not reported in the
CAPE program). A the educational sessions, a total of
1896 women were deemed eligible for HPV testing and
were scheduled for screening appointments to take place
at their local health clinics.
For this nested study, trained interviewers, hired spe-
cifically for this Adherence Study went to educational
sessions conducted by each of the four health units
(eight interviewers total) to randomly select one-third of
the women attending until a target sample of 409
women enrolled. The Adherence Study stopped enrol-
ling at a preset target of 409 screening participants. This
number was chosen so that there was 80 % power to de-
tect a difference of 15 % or greater in the appointment
attendance between those who had a history of screen-
ing versus those who did not (i.e., had not been screened
within the previous 3 years).
Upon arrival to the educational session, the first 18
women were given a card that was one of three colors,
distributed in an alternating fashion; one color was chosen
at random to select one-third of the women for invitation
to the Adherence Study. Thus, a maximum of six inter-
views were performed at each educational session.
Prior to the start of the educational session, research
assistants obtained informed consent from the selected
women and conducted a brief interview. Women were
asked about frequency of healthcare-related visits, rea-
sons for visits, and barriers to healthcare utilization, and
the distance, travel time, and method of transportation
required to visit their healthcare providers. They were
also asked about their previous cervical cancer screening
history, knowledge of HPV and cervical cancer risk
Fig. 1 Recruitment and adherence to screening for Phase one of the CAPE project and the nested study of Factors Determining Screening
Adherence, Paracentral Region, El Salvador
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factors, and demographic information. Reasons for non-
adherence to previous screening opportunities as well as
reasons for non-adherence to clinic visits when ill were
also elicited. The women then rejoined the rest of the
group for the educational session, which was presented
by either a clinician or a health promoter and covered
topics such as HPV, cervical cancer, screening methods,
HPV testing, self-sampling and provider-collected sam-
pling, interpreting HPV results, and possible treatments.
As part of the CAPE program, all women who attended
the educational talk were given the option of scheduling an
appointment 15 days after the session. To verify whether
women enrolled in the Adherence Study adhered to their
screening appointment, research assistants reviewed the ap-
pointment book weekly to report women as having
attended or missed their appointment. Women were con-
sidered adherent if they attend the scheduled appointment
or if they missed the scheduled appointment but resched-
uled and attended screening within the following 6 months.
Adherence to screening was calculated for both the
women enrolled in the Adherence Study and all women
recruited as part of the CAPE program. Within the Adher-
ence Study, Chi-square tests of significance were used to
assess the association between non-adherence and demo-
graphic variables (age, marital status, educational attain-
ment, employment status, household size, and obstetrical
parity); personal history of medical conditions (cancer, dia-
betes, heart disease, hypertension, and depression); family
history of cancer; sexual history (age of sexual initiation,
number of lifetime sexual partners, number of sexual part-
ners in the past 3 months, and history of sexually trans-
mitted infections); current birth control method; cervical
cancer screening history (provider recommendation for
cervical cancer screening within the past 3 years, time
since last cervical cancer screening); and structural bar-
riers to screening (distance and transportation time from
their home to health clinic, type of transportation used to
attend screenings, whether someone in their household
owns a car). The significance level was set at 0.05 and all
statistical analyses were conducted using STATA version
12.1 analytic software (StataCorp LP, College Station, TX).
Logistic regression was used to explore the relationship
between the independent variables listed above and adher-
ence to screening. Adjusting variables with P values less
than 0.10 in the bivariate analyses (Tables 1–3) were in-
cluded in the unadjusted logistic regression models. Vari-
ables with p-values less than 0.10 in unadjusted models
were entered into the reduced model using backwards
elimination. Significance for variables in reduced models
was set at p < 0.05.
Results
Among 1896 women who attended the education session
for the CAPE program and were eligible for screening,
410 (21.6 %) were randomly selected to participate in the
Adherence Study and all but one (99.8 %) provided con-
sent (Fig. 1). Adherence to screening was similar between
women participating in the Screening Adherence study
(88.0 % of 409) compared to women not participating
(85.5 % of 1487; p = 0.23) (Fig. 1).
Among the 409 women who participated in the
Adherence Study, demographic characteristics, personal
history of cancer, and screening attendance are presented
Table 1 Socio-demographic characteristics and family history in







N % n % n %
Total 409 100.0 360 100.0 49 100.0
Age (years)
30–34 139 34.0 123 34.2 16 32.7
35–39 122 29.8 105 29.2 17 34.7
40–44 94 23.0 80 22.2 14 28.6
45–49 51 13.2 52 14.4 2 4.1 .19
Highest education
Elementary/none 216 52.8 190 52.8 26 53.1
Middle school 153 37.4 133 36.9 20 40.8
High school or higher 40 9.8 37 10.3 3 6.1 .69
Marital status
Married 199 48.7 178 49.4 21 42.9
Living together 121 29.6 102 28.3 19 38.8
Single/widowed/
separated
89 21.8 80 22.2 9 18.4 .32
Number of children
0–2 113 27.6 101 28.1 12 24.5
3–4 178 43.5 155 43.1 23 46.9
> 5 118 28.9 104 28.9 14 28.6 .84
Size of household
1–3 20 4.9 18 5.0 2 4.1
4–5 137 33.5 117 32.5 20 40.8
> 6 252 61.6 225 62.5 27 55.1 .51
Work outside home 95 23.2 82 22.8 13 26.5 .56
Provider has told you that
you have:
Cancer 4 1.0 4 1.1 0 0.0 1.0
Diabetes 14 3.4 12 3.3 2 4.1 .68
Heart disease 15 3.7 14 3.9 1 2.0 1.0
High blood pressure 50 12.2 42 11.7 8 16.3 .38
Depression 46 11.3 40 11.1 6 12.2 .81
Family member has
had cancer
51 12.5 43 11.9 8 16.3 .38
aChi-square or Fisher’s exact test
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in Table 1. The average age of participants was 37.6 years,
and the majority were either married or living with their
partner. Most had more than three children, lived in a
household with at least six other individuals, had not com-
pleted a middle school education, and did not work out-
side of the home.
Sexual history, screening experience, and the associa-
tions with attendance are presented in Table 2. More than
half of participants reported first sexual activities occurred
between 16 and 19 years of age, and 85 % of participants
reported sexual activity with one partner within the last
3 months. Approximately 50 % of participants reported
one lifetime partner, and most of the remaining women
reporting 2–3 lifetime partners (44.3 %; range of 1–50
partners). Only 1.5 % of patients reported any condom
use, and 17.4 % reported having had a previous sexually
transmitted infection. A majority of participants stated
that a provider had recommended a cervical cancer
screening within the past 3 years (64.8 %), and 77.2 % of
women reported having participated in screening within
the past 3 years. A higher number of lifetime sexual part-
ners and a longer period of time since the last cervical
cancer screening were the only variables significantly asso-
ciated with non-attendance to the screening appointment
(p = 0.03 and p = 0.04, respectively).
Adherence and structural barriers to cervical cancer
screening are presented in Table 3. At the interview,
100.0 % of patients reported willingness to attend
screening; 88.0 % attended their screening appointment.
The vast majority lived less than 10 km from a health
clinic and required public transportation for travel. Al-
though most women required less than a half hour of
travel time to reach the clinic, 14.2 % of patients re-
ported requiring more than 1 h to travel to the clinic.
These findings were consistent when adjusting for age.
Multivariate analysis of variables potentially associated
with adherence (including age) showed that after







n % n % n %
Total 409 100.0 360 100.0 49 100.0
Age of first intercourse
(years)
< 16 83 20.5 75 21.1 8 16.3
16–19 210 51.9 189 53.1 21 42.9
> 20 112 27.7 92 25.8 20 40.8 .09
Number of lifetime
sexual partners
1 189 47.0 167 47.2 22 45.8
2–3 178 44.3 161 45.5 17 35.4
> 4 35 8.7 26 7.3 9 18.8 .03
Number of partners
in past 3 months
Zero 57 14.1 54 15.2 3 6.3
One 343 85.1 299 84.2 44 91.7
Two or more 3 0.8 2 0.6 1 2.0 .10
Current birth
control method
1 month injection 13 3.2 12 3.3 1 2.0
2 month injection 33 8.1 29 8.1 4 8.2
3 month injection 57 14.0 45 12.5 12 24.5
Tubal ligation 88 21.6 80 22.3 8 16.3
Other 20 4.9 16 4.5 4 8.2
None 197 48.3 177 49.3 20 40.8 .21
Ever had an STI 71 17.4 61 17.0 10 20.4 .59
Provider recommended
screening in past 3 years
265 64.8 237 65.8 28 57.1 .23
Last screen for
cervical cancer
</=3 years ago 312 77.2 281 78.9 31 64.6
> 3 years ago 81 20.1 67 18.8 14 29.2
Never 11 2.7 8 2.3 3 6.3 .04
aChi-square or Fisher’s exact test







n % n % n %
Total 409 100.0 360 100.0 49 100.0
Distance to clinic
from home
< 10 km 330 80.7 295 81.9 35 71.4
10–20 km 39 9.5 33 9.2 6 12.2
> 20 km 40 9.8 32 8.9 8 16.3 .18
Main transport method
to clinicb
Walking 68 16.6 58 16.1 10 20.4
Personal vehicle 6 1.5 6 1.7 0 0.0
Friend’s vehicle 30 7.3 25 6.9 5 10.2
Public transport 305 74.6 271 75.5 34 69.4 .56
Someone in home
owns a car
58 14.2 51 14.2 7 14.3 .98
Time to get to clinic
from home
< 5 min 38 9.3 36 10.0 2 4.1
> 5–30 min 218 53.3 195 54.2 23 46.9
> 30–60 min 95 23.2 79 21.9 16 32.7
> 60 min 58 14.2 50 13.9 8 16.3 .23
aChi-square or Fisher’s exact test
b1 woman reported friend’s vehicle
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adjustment, having four or more sexual partners, a time
period of greater than 3 years from previous screening,
or never having had screening continued to be statisti-
cally associated with non-adherence (Table 4).
Under-screened women were asked specifically about
why they had not been screened recently, and women re-
ported that cervical cancer screening in particular was
painful (61.4 %), uncomfortable or embarrassing (64.3 %),
and women did not like having to see male providers
(71.4 %). Many women were unsure of the purpose of a
Pap test (61.4 %), did not recall any suggestions around
screening from their providers (65.7 %), or believed that
cervical cancer screening was unnecessary (65.7 %).
Discussion
This study examined factors associated with adherence to
a scheduled appointment for cervical cancer screening
using HPV DNA testing. The most important finding of
this study was that the attendance rate was excel-
lent—88.0 % of women in this study attended their sched-
uled appointment. Programmatic influences that may
have contributed to the high appointment adherence in-
clude interaction with local health promoters, the educa-
tional seminar, a novelty effect in that the test was new to
the region, and the fact that the program was advertised
as potentially allowing women to not require further
screening for at least 5 years. Some of these variables have
been elicited in past studies that have found educational
programs to increase screening participation [6–9].
The design of the CAPE program involved health pro-
moters meeting women both at their homes and at the
educational session. This outreach method is standard
for the Salvadoran MOH and has been increasing glo-
bally, with the governments of Nepal, Ethiopia, Ghana,
and Iran aiming to use door-to-door outreach on a
national level. In our study, we found an unanticipated
factor was the enthusiasm of the health promoters: with-
out instruction from researchers, many health promoters
displayed initiative in reminding women of upcoming
appointments, contacted patients to reschedule if the
previous appointment was missed, or helped provide
transportation for women to attend the educational ses-
sions and screening appointments. As a result, logistical
barriers were not associated with a significant decrease in
adherence to screening. The level of interaction varied
among health promoters, but having local representatives
communicate with women repeatedly throughout the
scheduling and screening process clearly contributed to
the high rate of attendance. This finding is in accord with
findings from previous studies regarding communication
with patients prior to scheduled appointments [6–8].
The use of health promoters in the implementation
of screening programs is a sustainable strategy over
time, especially in the context of El Salvador. Past stud-
ies have shown the benefit of using educational pro-
grams to increase screening rates, and this study
further reinforces the role of health promoters in
achieving this public health goal [6–9]. Health pro-
moters are women employed by the Ministry of Health
responsible for educating and working with a given
number of people within a service area. The focus of
their work is on the prevention of cervical cancer, and
their efforts and training are part of a bigger plan to
scale up CAPE at a national level. Cervical cancer pre-
vention and screening programs have shown evidence
of greater patient follow-through when the target com-
munity is directly involved in the implementation of
services [17]. These contributions likely helped to in-
crease our adherence rate and provide a guide for pro-
grammatic improvements in the future.
Table 4 Odds ratios (OR) and 95 % confidence intervals (CI) of attending screening for factors associated with screening attendance
Univariate OR (95 % CI) of attending screening Multivariate OR (95 % CI) of attending screening
Odds ratio (OR) 95 % Confidence Interval (CI) Odds ratio (OR) 95 % Confidence Interval (CI)
Age of first intercourse (years)
< 16 1.00 − − −
16–19 1.05 0.45–2.48 − −
> 20 2.18 0.90–5.27 − −
Number of lifetime sexual partners
1 1.00 − 1.00 −
2–3 0.80 0.41–1.56 0.74 0.37–1.46
> 4 2.60 1.08–6.28 2.69 1.10–6.56
Last screen for cervical cancer
</=3 years ago 1.00 − 1.00 −
> 3 years ago 2.00 1.00–4.01 2.06 1.02–6.56
Never 3.32 0.83–13.2 4.78 1.14–19.95
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It should be noted that the two factors that were asso-
ciated with non-adherence to screening were higher
number of lifetime sexual partners and longer time since
last cervical cancer screening, indicating that those with
greatest need for screening were least likely to attend.
Prior literature finds that women with high-risk behavior
including cigarette smoking, unprotected sexual inter-
course, acute alcohol consumption, and women with
multiple sexual partners are less likely to seek preventive
medical interventions [18, 19]. Certain high-risk behav-
iors such as smoking and alcohol consumption were not
studied in detail here. Smoking, alcohol abuse, and en-
gaging in high-risk sexual behavior, such as having mul-
tiple sexual partners, are not common practices amongst
women in El Salvador and therefore do not contribute
significantly to cervical carcinogenesis in this population
[4]. A previous study conducted in the same region of El
Salvador found that very few women in the area had
ever smoked [20].
Interestingly, our study did not show an association
between screening adherence and use of contraception,
age, and education as other studies have. The fact that
the majority of women in this study had been recently
screened might explain the lack of observed association.
An important limitation of this study was that the
population included was likely not representative of all
women from a rural Salvadoran community. By design,
women not attending the educational session could not
participate in the study. These constituted perhaps 23 %
of women in the rural community. It is likely that
women failing to attend an educational session were
least likely to attend screening. This selection bias is evi-
denced in the high proportion of women enrolled in the
adherence study who received screening in the past
3 years (77 %). This is higher than expected from a
country where 1-year cervical cancer coverage estimates
range from 17 to 42 % [21, 22]. This limitation is perva-
sive in cervical cancer screening studies which are highly
populated by healthcare seekers. In this instance, the be-
havior may have uncovered a converse behavior with
health promoters seeking women who will comply. Re-
gardless, the data identifies a few important areas (e.g.,
educational sessions and home-based recruitment by
health promotors) improved adherence that should be
addressed in the future. In addition, El Salvador is a
fairly homogenous country and the CAPE program was
designed to capture most of the Paracentral region
which we expect to generalize to the whole country.
Conclusions
In conclusion, the educational sessions by individuals
who live in these communities and the use of health
promoters may be effective in recruiting and scheduling
HPV screening appointments. Overall, adherence to
screening was high, yet women with a history of non-
screening as well as those with more lifetime sexual
partners were less likely to attend. Further studies are
needed to identify effective recruitment methods tar-
geted at this at-risk population.
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